IPCA Labs Acquires Stake in Unichem Laboratories:
IPCA Laboratories has recently announced that the board has entered into a definitive agreement to acquire a 33.38 percent stake in Unichem Laboratories. The deal is valued at Rs 1,034.06 crore and is expected to benefit both companies in terms of product offerings and business growth.
Unichem Laboratories, which has formulations manufacturing facilities in Goa, Ghaziabad, and Baddi, and API manufacturing facilities in Roha, Pitampur, and Kohlapur, is confident that IPCA is the right partner to lead its business to the next phase of growth. Meanwhile, IPCA Laboratories’ Promoter and Executive Chairman, Premchand Godha, believes that the two companies are well-positioned to integrate their product offerings and grow their businesses together.
Unichem Laboratories was the subject of potential corporate development on April 5. The company’s shares saw their best single-day performance in 16 months, ending 3.5 percent higher at Rs 390, while IPCA Labs’ shares ended lower by 1.8 percent.
Overall, this acquisition marks a positive step forward for both companies and their growth prospects in the pharmaceutical industry.
About IPCA Labs:
Headquartered in Mumbai, India, Ipca Laboratories Ltd is a multinational pharmaceutical corporation. Its core product range comprises active pharmaceutical ingredients, including theobromine, acetyl-thiophene, and p-bromotoluene. These APIs and their intermediates are marketed worldwide by Ipca.
For More Latest News Click Here
